Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pulse Biosciences

17.91
-1.3600-7.06%
Post-market: 17.910.00000.00%17:40 EDT
Volume:189.70K
Turnover:3.46M
Market Cap:1.20B
PE:-19.52
High:19.45
Open:19.32
Low:17.55
Close:19.27
Loading ...

Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer

THOMSON REUTERS
·
04 Feb

Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer

Business Wire
·
04 Feb

Pulse Biosciences’ Nanosecond PFA Technology to Be Featured in Presentations at North American Society for Interventional Thyroidology Annual Meeting

Business Wire
·
30 Jan

Pulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360° Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium

Business Wire
·
21 Jan

Pulse Biosciences Updates Investors on Cardiac Innovations

TIPRANKS
·
14 Jan

Pulse Biosciences Appoints Paul LaViolette as CEO

TIPRANKS
·
14 Jan

Pulse Biosciences’ Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Symposium

Business Wire
·
13 Jan

Pulse Biosciences Names Paul LaViolette CEO

MT Newswires Live
·
10 Jan

Pulse Biosciences Appoints Co-Chairman Paul LaViolette as CEO

Dow Jones
·
10 Jan

Pulse Biosciences, Inc. Appoints Paul Laviolette as Chief Executive Officer

THOMSON REUTERS
·
10 Jan

Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer

Business Wire
·
10 Jan

BRIEF-Pulse Biosciences Announces Planned Redemption Of Warrants

Reuters
·
24 Dec 2024

Pulse Biosciences, Inc. Announces Planned Redemption of Warrants

THOMSON REUTERS
·
24 Dec 2024

Pulse Biosciences, Inc. Announces Planned Redemption of Warrants

Business Wire
·
24 Dec 2024

Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants

Business Wire
·
19 Dec 2024

Pulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular Surgery

Business Wire
·
17 Dec 2024

Robert Duggan Spends US$972k On Pulse Biosciences Stock

Simply Wall St.
·
16 Dec 2024

Top Key Executive Robert Duggan, Pulse Biosciences, Inc.'s (NASDAQ:PLSE) largest shareholder sees value of holdings go down 13% after recent drop

Simply Wall St.
·
12 Dec 2024

Pulse Biosciences CEO Resigns Amid Leadership Transition

TIPRANKS
·
07 Dec 2024

Pulse Biosciences Inc - CEO Burke T. Barrett to Resign Effective December 6, 2024

THOMSON REUTERS
·
07 Dec 2024